RxLive, Inc. announced that it has received $5.049561 million in funding from SpringTide Capital Management LLC, Cardinal Health, Inc. and other investors

On September 23, 2022, RxLive, Inc. closed the transaction. The company received $6,689,561 in the transaction. The company raised $1,689,561 in its final tranche.

The transaction included participation from 8 investors.